Enzyme-Triggered Disassembly of Polymeric Micelles by Controlled Depolymerization via Cascade Cyclization for...

Area of Science:

• Biomaterials Science
• Nanotechnology
• Cancer Therapeutics

Background:

• Enzyme activity in cancer cells, such as NAD(P)H:quinone oxidoreductase-1 (NQO1), is a key target for cancer diagnosis and drug delivery.
• NQO1 is overexpressed in certain tumors, playing a role in homeostasis and mitigating oxidative stress from reactive oxygen species (ROS).
• NQO1's interaction with quinone propionic acid (QPA) facilitates a cyclization reaction.

Purpose of the Study:

• To design and synthesize an NQO1-responsive amphiphilic block copolymer for targeted drug delivery.
• To create self-assembled micelles capable of controlled drug release triggered by NQO1 activity.
• To evaluate the efficacy of these NQO1-responsive micelles in cancer treatment.

Main Methods:

• Synthesis of an amphiphilic block copolymer (QPA-P) comprising NQO1-cleavable QPA-locked polycaprolactone (PCL) and poly(ethylene glycol) (PEG).
• Formation of self-assembled micelles from QPA-P in aqueous environments.
• Investigation of NQO1-catalyzed depolymerization of QPA-P via a two-step cyclization process, leading to micelle dissociation and drug release.

Main Results:

• The synthesized QPA-P copolymer successfully formed stable micelles in aqueous conditions.
• NQO1 enzyme effectively catalyzed the depolymerization of the QPA-locked PCL component through a cascade cyclization.
• This enzymatic activity led to micellar structure dissociation and triggered the release of encapsulated drugs specifically at cancer cells.
• NQO1-responsive micelles demonstrated enhanced intracellular drug release and improved anticancer effects compared to controls.

Conclusions:

• NQO1-responsive polymeric micelles represent a promising strategy for targeted anticancer drug delivery.
• The NQO1-triggered drug release mechanism enhances therapeutic efficacy by concentrating treatment at tumor sites.
• This approach holds significant potential for improving the overall effectiveness of cancer therapeutic systems.